1. Home
  2. IMUX vs MNSB Comparison

IMUX vs MNSB Comparison

Compare IMUX & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunic Inc.

IMUX

Immunic Inc.

BUY

Current Price

$7.62

Market Cap

155.8M

Sector

Health Care

ML Signal

BUY

Logo MainStreet Bancshares Inc.

MNSB

MainStreet Bancshares Inc.

SELL

Current Price

$24.80

Market Cap

164.1M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
IMUX
MNSB
Founded
2016
2003
Country
United States
United States
Employees
66
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
155.8M
164.1M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
IMUX
MNSB
Price
$7.62
$24.80
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
★ $43.09
N/A
AVG Volume (30 Days)
★ 385.8K
20.9K
Earning Date
11-12-2026
10-26-2026
Dividend Yield
N/A
★ 1.61%
EPS Growth
38.00
★ 210.00
EPS
N/A
★ 1.05
Revenue
N/A
★ $135,615,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$23.63
Revenue Growth
★ N/A
N/A
52 Week Low
$0.51
$17.86
52 Week High
$17.43
$25.87

Technical Indicators

Market Signals
Indicator
IMUX
MNSB
Relative Strength Index (RSI) 23.18 49.62
Support Level $0.78 $24.24
Resistance Level $15.82 $25.27
Average True Range (ATR) 0.65 0.50
MACD -0.11 -0.04
Stochastic Oscillator 3.43 59.40

Price Performance

Historical Comparison
IMUX
MNSB

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

Share on Social Networks: